Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophrenia by Liu W, Downing A C M, Munsie L M, Chen P, Reed M R, Ruble C L, Landschulz K T, Kinon B J, Nisenbaum L K in The pharmacogenomics journal (2010).

[PMID: 21173788] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.